Arellano, Celgwen Mae Q.
HRN: 27-35-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2025
CEFTRIAXONE 1G (VIAL)
06/20/2025
06/27/2025
IV
2grams
Once Daily
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes